Journal Information

Statistics

Follow this link to access the full text of the article

Case Letter
Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis
Busra Demirbag Gula,
Corresponding author
busrademirbag@windowslive.com

Corresponding author.
, Nilgun Senturka, Deniz Baycelebib, Levent Yildizb
a Department of Dermatology, Ondokuz Mayıs University, Faculty of Medicine, Samsun, Turkey
b Department of Pathology, Ondokuz Mayıs University, Faculty of Medicine, Samsun, Turkey
Read
3438
Times
was read the article
1589
Total PDF
1849
Total HTML
Share statistics
Article information
ISSN: 03650596
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 March 66 61 127
2024 February 109 74 183
2024 January 72 51 123
2023 December 42 63 105
2023 November 68 75 143
2023 October 72 86 158
2023 September 68 60 128
2023 August 49 32 81
2023 July 58 42 100
2023 June 54 34 88
2023 May 36 29 65
2023 April 33 19 52
2023 March 51 57 108
2023 February 42 36 78
2023 January 44 67 111
2022 December 49 34 83
2022 November 70 44 114
2022 October 214 61 275
2022 September 46 72 118
2022 August 46 68 114
2022 July 51 50 101
2022 June 72 58 130
2022 May 74 52 126
2022 April 60 63 123
2022 March 66 74 140
2022 February 87 59 146
2022 January 110 95 205
2021 December 37 65 102
2021 November 3 8 11
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.